Sanofi in talks to sell generics arm Zentiva to Advent for 1.9 billion euros

Retrieved on: 2018-04-16 14:45:00

Tags for this article:

Business

Economy

Click the tags to see associated articles and topics

Sanofi in talks to sell generics arm Zentiva to Advent for 1.9 billion euros. View article details on hiswai:

Excerpt

<div>PARIS (Reuters) - French healthcare group Sanofi (SASY.PA) has started exclusive talks with private equity firm Advent International over selling its Zentiva European generics drugs arm to Advent for 1.9 billion euros ($2.4 billion), the companies said. FILE PHOTO: French multinational pharmaceutical ...</div>

Article found on:

View Original Article